Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut

[1]  R. Carare,et al.  Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials , 2021, Frontiers in Neuroscience.

[2]  M. Mintun,et al.  Donanemab in Early Alzheimer's Disease. , 2021, The New England journal of medicine.

[3]  R. Carare,et al.  Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy , 2020, Alzheimer's Research & Therapy.

[4]  M. Zasloff,et al.  Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease. , 2020, Journal of Parkinson's disease.

[5]  C. Holmes,et al.  Neuroinflammation in dementia with Lewy bodies: a human post-mortem study , 2020, Translational Psychiatry.

[6]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[7]  K. Shannon,et al.  Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease , 2020, Neurobiology of Disease.

[8]  M. Guerra-Crespo,et al.  Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles , 2020, Frontiers in Neuroscience.

[9]  Han-Joon Kim,et al.  Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies , 2019, Journal of movement disorders.

[10]  Bin Zhang,et al.  Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration , 2019, Nature Communications.

[11]  P. McLean,et al.  Cellular models of alpha‐synuclein toxicity and aggregation , 2019, Journal of neurochemistry.

[12]  D. Brooks,et al.  Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease , 2019, European journal of neurology.

[13]  Paramita Chakrabarty,et al.  α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease , 2019, Acta Neuropathologica.

[14]  Alan J. Thomas,et al.  Dementia with Lewy bodies: an update and outlook , 2019, Molecular Neurodegeneration.

[15]  M. Romero-Ramos,et al.  Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention , 2018, Front. Cell. Neurosci..

[16]  Xiaochun Chen,et al.  Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease , 2018, Medicine.

[17]  M. Zaheer,et al.  Frequency of non-motor symptoms in Parkinson’s disease presenting to tertiary care centre in Pakistan: an observational, cross-sectional study , 2018, BMJ Open.

[18]  Wei Zhang,et al.  Parkinson disease with constipation: clinical features and relevant factors , 2018, Scientific Reports.

[19]  Zheng-Xiong Xi,et al.  Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia , 2017, Neuron.

[20]  B. Pakkenberg,et al.  Changes in the cell population in brain white matter in multiple system atrophy , 2017, Movement disorders : official journal of the Movement Disorder Society.

[21]  Pei-Ning Wang,et al.  UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's disease , 2017, Alzheimer's & dementia.

[22]  E. Masliah,et al.  Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice , 2017, BMC Neuroscience.

[23]  Daniela Berg,et al.  Advances in markers of prodromal Parkinson disease , 2016, Nature Reviews Neurology.

[24]  S. Hamilton-Dutoit,et al.  Pathological α‐synuclein in gastrointestinal tissues from prodromal Parkinson disease patients , 2016, Annals of neurology.

[25]  R. Melki,et al.  Structural and functional properties of prefibrillar α-synuclein oligomers , 2016, Scientific Reports.

[26]  Seung-Jae Lee,et al.  Mechanism of Anti-α-Synuclein Immunotherapy , 2016, Journal of movement disorders.

[27]  Bente Pakkenberg,et al.  Neocortical Neuronal Loss in Patients with Multiple System Atrophy: A Stereological Study , 2015, Cerebral cortex.

[28]  S. Kish,et al.  Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation , 2015, Neurobiology of Disease.

[29]  Tessandra H Stewart,et al.  α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation , 2015, Proceedings of the National Academy of Sciences.

[30]  W. Boesmans,et al.  Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system , 2015, Glia.

[31]  William W. Agace,et al.  Regional specialization within the intestinal immune system , 2014, Nature Reviews Immunology.

[32]  E. Hol,et al.  Enteric GFAP expression and phosphorylation in Parkinson's disease , 2014, Journal of neurochemistry.

[33]  E. Masliah,et al.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials , 2014, Acta Neuropathologica.

[34]  C. Carroll,et al.  Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease , 2014, Acta Neuropathologica.

[35]  Ting-ting Yang,et al.  Differential distribution and activation of microglia in the brain of male C57BL/6J mice , 2013, Brain Structure and Function.

[36]  D. Devos,et al.  Colonic inflammation in Parkinson's disease , 2013, Neurobiology of Disease.

[37]  A. Lees,et al.  Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease , 2012, Annals of neurology.

[38]  E. Masliah,et al.  Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission , 2012, The Journal of Neuroscience.

[39]  M. Chesselet,et al.  Mice overexpressing wild‐type human alpha‐synuclein display alterations in colonic myenteric ganglia and defecation , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[40]  A. Winslow,et al.  Exosomal cell-to-cell transmission of alpha synuclein oligomers , 2012, Molecular Neurodegeneration.

[41]  M. Chesselet,et al.  A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice , 2012, Neurotherapeutics.

[42]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[43]  K. Krogh.  Gastrointestinal Dysfunction in Parkinson’s Disease , 2011 .

[44]  Evangelia Emmanouilidou,et al.  Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma , 2011, PloS one.

[45]  E. Masliah,et al.  Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.

[46]  P. Lockhart,et al.  Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression , 2009, Journal of neuropathology and experimental neurology.

[47]  G. Vighi,et al.  Allergy and the gastrointestinal system , 2008, Clinical and experimental immunology.

[48]  H. Braak,et al.  Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease , 2007, Acta Neuropathologica.

[49]  Changcai Wang,et al.  Site-specific UBITh® amyloid-β vaccine for immunotherapy of Alzheimer's disease , 2007 .

[50]  G. Halliday,et al.  A possible role for humoral immunity in the pathogenesis of Parkinson's disease. , 2005, Brain : a journal of neurology.

[51]  Smita Patel,et al.  Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates , 2005, The Journal of Neuroscience.

[52]  Makoto Hashimoto,et al.  Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease , 2005, Neuron.

[53]  F. Helmchen,et al.  Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.

[54]  Jonathan Salcedo,et al.  Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein , 2004, The Journal of Neuroscience.

[55]  C. Holmes,et al.  Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.

[56]  P. Wade,et al.  Aging and neural control of the GI tract. I. Age-related changes in the enteric nervous system. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[57]  M. Dailey,et al.  Dynamics of microglial activation: A confocal time‐lapse analysis in hippocampal slices , 2001, Glia.

[58]  R. Mohney,et al.  Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.

[59]  V. Perry,et al.  Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain , 1990, Neuroscience.

[60]  A. Jonas,et al.  The mouse in biomedical research. , 1984, The Physiologist.

[61]  S. Qualman,et al.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia: Similarity to Parkinson's disease , 1984 .

[62]  C. Adler,et al.  Does Parkinson’s disease start in the gut? , 2017, Acta Neuropathologica.

[63]  K. Walters,et al.  Prediagnostic presentations of Parkinson's disease in primary care: a case-control study , 2015, The Lancet Neurology.

[64]  Andrew Siderowf,et al.  Parkinson's at risk syndrome: Can Parkinson's disease be predicted? , 2010, Movement disorders : official journal of the Movement Disorder Society.

[65]  Changcai Wang,et al.  Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease. , 2007, Vaccine.

[66]  E. Masliah,et al.  Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. , 2005, Neuron.

[67]  Hitoshi Takahashi,et al.  Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses , 2004, Acta Neuropathologica.

[68]  M. Chesselet,et al.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[69]  K. Bitar.  Aging and neural control of the GI tract: V. Aging and gastrointestinal smooth muscle: from signal transduction to contractile proteins. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[70]  S. Qualman,et al.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. , 1984, Gastroenterology.